Transcriptomics

Dataset Information

0

Combination of triciribine and p38 inhibitors enhances the differentiation effect on myeloid leukemia cells


ABSTRACT: Differentiation therapy with all-trans retinoic acid (ATRA) is well established for acute promyelocytic leukemia (APL). However, the narrow application and tolerance development of ATRA remain to be improved. A number of kinase inhibitors have been reported to induce differentiation. In this study, we challenged several combinations of these kinase inhibitors. As a result, we found that the combination of Akt inhibitor Triciribine (TCN) and several p38 MAPK inhibitors have profound effect for differentiation in several myeloid cell lines. To reveal the molecular mechanisms involved in TCN and p38 MAPK inhibitor induced differentiation, we performed microarray analysis.

ORGANISM(S): Homo sapiens

PROVIDER: GSE235632 | GEO | 2023/06/27

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2006-12-19 | GSE3866 | GEO
2009-04-25 | E-GEOD-3866 | biostudies-arrayexpress
2018-06-15 | GSE29587 | GEO
2013-09-05 | E-GEOD-50591 | biostudies-arrayexpress
2022-01-21 | GSE183999 | GEO
2007-12-30 | GSE6820 | GEO
2021-11-24 | PXD026904 | Pride
2017-07-01 | E-MTAB-1210 | biostudies-arrayexpress
2014-12-25 | GSE53712 | GEO
2024-01-01 | GSE223329 | GEO